TNYA as of Nov 3 · 06:15 ET
TNYANasdaqBiological Products, (No Diagnostic Substances)

Tenaya Therapeutics, Inc. · Brief

Next report

6 days

Nov 9 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±51.0%▼−7.51%×0.15
quarterimplied−55%0+55%realized×
Q2 FY26±51.0%▼−7.51%×0.15
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

13managers whose positions together account for most of the reported value13F · Jun 30 '26
+8.36%shares held by the ten largest reporting managers rose over the latest quarter13F · Jun 30 '26

Bear1

6 of 24of the largest reporting managers trimmed their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

TNYA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 27impliedImplied move: ±79.4% into Nov 9 earnings (Oct 27 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.